Skip to content

Drug interactions

Atogepant + Crizotinib

Severity: Moderate

Atogepant and Crizotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib is a moderate CYP3A4 inhibitor and can raise atogepant exposure. This may increase atogepant adverse effects such as nausea, constipation and fatigue.

What this interaction means in plain words

Atogepant and Crizotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atogepant belongs to Central Nervous System; Crizotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Crizotinib inhibits CYP3A4-mediated metabolism of atogepant, increasing its exposure.

What to do

Limit atogepant to a reduced dose of 10 mg daily for the prevention of episodic migraine when used with a CYP3A4 inhibitor, and monitor tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Crizotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Crizotinib?

MediHelp rates the interaction as moderate. Atogepant and Crizotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Crizotinib is a moderate CYP3A4 inhibitor and can raise atogepant exposure. This may increase atogepant adverse effects such as nausea, constipation and fatigue.

How serious is the interaction between Atogepant and Crizotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit atogepant to a reduced dose of 10 mg daily for the prevention of episodic migraine when used with a CYP3A4 inhibitor, and monitor tolerability.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in